Licenses, Net - Additional Information (Details) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|---|
|
Jun. 30, 2021
USD ($)
$ / shares
shares
|
Sep. 30, 2020
USD ($)
|
Sep. 30, 2021
USD ($)
|
Sep. 30, 2020
USD ($)
|
Dec. 31, 2017
USD ($)
item
shares
|
Dec. 31, 2020
USD ($)
|
|
| Licenses Net [Line Items] | ||||||
| Shares issued value | $ 15,500,002 | $ 97,789,038 | $ 26,750,002 | |||
| Licensing agreements | ||||||
| Licenses Net [Line Items] | ||||||
| Number of license acquired | item | 2 | |||||
| Licenses, Net | 1,514,747 | $ 466,131 | ||||
| Value of shares development milestones | $ 1,404,750 | $ 544,889 | ||||
| First license agreements | ||||||
| Licenses Net [Line Items] | ||||||
| Licenses, Net | $ 114,967 | |||||
| Amortization period (in years) | 10 years | |||||
| Second license agreements | ||||||
| Licenses Net [Line Items] | ||||||
| Patent application costs | $ 75,702 | |||||
| Company awarded shares | shares | 25,000 | |||||
| Shares issued value | $ 128,750 | |||||
| Issuance of shares development milestones | shares | 75,000 | 75,000 | ||||
| Market value per share | $ / shares | $ 18.73 | |||||
| Value of shares development milestones | $ 1,404,750 | |||||
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount represents the finite lived intangible assets addition. No definition available.
|
| X | ||||||||||
- Definition The amount of reimbursement of patent application cost. No definition available.
|
| X | ||||||||||
- Definition Licenses Net [Line Items] No definition available.
|
| X | ||||||||||
- Definition Market Value of shares issuable. No definition available.
|
| X | ||||||||||
- Definition Number of license acquired. No definition available.
|
| X | ||||||||||
- Definition Number of shares issuable based on developmental milestones. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|